| Role |
Name |
Disclosure |
Details |
| Author | Ulrike M Reiss, MD, Assistant Member, Department of Hematology, St Jude Children's Research Hospital | Nothing to disclose | Details | | Coauthor | Pedro A de Alarcon, MD, William H Albers Professor and Chair, Department of Pediatrics, University of Illinois College of Medicine at Peoria | Nothing to disclose | Details | | Coauthor | Frank E Shafer, MD, Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, St. Christopher's Hospital for Children, MCP Hahnemann University School | Nothing to disclose | Details | | Medical Editor | J Martin Johnston, MD, Associate Professor of Pediatrics, Mercer University School of Medicine; Director of Pediatric Hematology/Oncology, Backus Children's Hospital; Consulting Oncologist/Hematologist, St Damien's Pediatric Hospital | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Steven K Bergstrom, MD, Assistant to the Chairman, Department of Pediatrics, Division of Hematology-Oncology, Kaiser Permanente Medical Center of Oakland | Nothing to disclose | Details | | CME Editor | Samuel Gross, MD, Professor Emeritus, Department of Pediatrics, University of Florida, Clinical Professor, Department of Pediatrics, UNC, Adjunct Professor, Department of Pediatrics, Duke University | Nothing to disclose | Details | | Chief Editor | Max J Coppes, MD, PhD, MBA, Executive Director, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Professor of Medicine, Oncology, and Pediatrics, Georgetown University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Frank E Shafer, Coauthor |
The contributor discloses no conflict of interest. |
|